dc.contributor.author | Kramer-Marek, G | |
dc.contributor.author | Oyen, WJG | |
dc.date.accessioned | 2016-09-28T10:52:20Z | |
dc.date.issued | 2016-07-01 | |
dc.identifier.citation | Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, 57 (7), pp. 996 - 1001 | |
dc.identifier.issn | 0161-5505 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/127 | |
dc.identifier.eissn | 1535-5667 | |
dc.identifier.doi | 10.2967/jnumed.115.169540 | |
dc.format | Print-Electronic | |
dc.format.extent | 996 - 1001 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | SOC NUCLEAR MEDICINE INC | |
dc.subject | Animals | |
dc.subject | Humans | |
dc.subject | Neoplasms | |
dc.subject | Positron-Emission Tomography | |
dc.subject | Treatment Outcome | |
dc.subject | Translational Medical Research | |
dc.subject | ErbB Receptors | |
dc.subject | Biomarkers | |
dc.title | Targeting the Human Epidermal Growth Factor Receptors with Immuno-PET: Imaging Biomarkers from Bench to Bedside. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2016-05-11 | |
rioxxterms.versionofrecord | 10.2967/jnumed.115.169540 | |
rioxxterms.licenseref.startdate | 2016-07 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Journal of nuclear medicine : official publication, Society of Nuclear Medicine | |
pubs.issue | 7 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Preclinical Molecular Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Preclinical Molecular Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Molecular Imaging | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Preclinical Molecular Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Preclinical Molecular Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Molecular Imaging | |
pubs.publication-status | Published | |
pubs.volume | 57 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Preclinical Molecular Imaging | |
icr.researchteam | Translational Molecular Imaging | |
dc.contributor.icrauthor | Kramer-Marek, Gabriela | |